Thiazolidine derivatives and their use

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Parasitic organism or component thereof or substance...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

548183, C07D27704, A61K 31425

Patent

active

043871011

ABSTRACT:
A thiazolidine derivatives of the formula: ##STR1## wherein R is a phenyl group having 2 nuclear substituent groups selected from the group consisting of a lower alkyl having 1 to 6 carbon atoms, a lower alkoxy having 1 to 7 carbon atoms, hydroxyl and a carboxylic acyloxy having 1 to 4 carbon atoms, or a phenyl group having a methylenedioxy group in adjacent positions on its ring; R.sup.1 is H or an alkyl having 1 to 6 carbon atoms, or a physiologically acceptable salt thereof is a novel compound having the activity to control certain chronic symptoms due to diabetes, such as diabetic cataract, diabetic neuropathy and diabetic retinosis.

REFERENCES:
patent: 2678318 (1952-10-01), Heilbron et al.
patent: 3311655 (1967-03-01), Boileau et al.
patent: 3825553 (1974-07-01), Diamond et al.
patent: 4186129 (1980-01-01), Huth et al.
patent: 4340605 (1982-07-01), Kawamatsu et al.
patent: 4349683 (1982-09-01), Bigg
Burton et al., Jour. of Medicinal Chemistry, vol. 13, pp. 1009-1012, (1970).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Thiazolidine derivatives and their use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Thiazolidine derivatives and their use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thiazolidine derivatives and their use will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2342969

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.